About
Envita Medical Centers was founded in 2001 by Dr. Dino Prato NMD. By 2005, Envita Medical Centers began researching building vaccines utilizing Natural Killer Cells to fight cancer and metastasis.
They identified a problem among advanced cancer patients with a great deal of commonality – impaired immunity. Upon learning about this development, the FDA issued a warning letter to Envita for not registering the biologics product as a new research drug with IND application.
In 2008 Envita was granted permission by the FDA an IND to pursue a phase one drug study using the body's own immune system to fight cancer. Being primarily an integrative medical center, Envita did not want to limit their biologics development and the opportunity to use Natural Killer Cell vaccines to help patients.
By observing the obstacles encountered with similar cancer vaccine pioneers, Envita did not choose to pursue its FDA study approval in the United States. Instead, Envita partnered with renowned international Hematologist/Oncologist and Bone Marrow Specialist Joel Badell MD and Professor Antonio Rascon , a chemical biologist with a specialization in clinical analysis.
After having collaborated on many successful patient treatments with these decorated specialists, Envita Mexico established its center in Hermosillo, Mexico. The center continues to thrive under the leadership of Dr. Badell and laboratory expertise of Dr. Rascon who continue to develop new bone marrow transplant methods, as well as mesychmal stem cell research. Envita's impressive history of treatment successes, coupled with new developments and improvements to our proprietary vaccine, Envita Mexico promises to be a world leader in Cancer Immunology.
The company's goal was to develop a new generation of therapeutics created from the body's own cell types that are naturally occurring and important in human health and disease. Within a few short years, Envita had proven it possible to produce customized vaccines and significantly help cancer patients. Today, Envita continues to use biologics engineering, techniques, and sophisticated technologies to develop medicines that address significant, specific, and previously unmet need, to provide clinical benefits to patients worldwide.
Envita's Scottsdale campus now serves as the headquarters for clinical care and treatment planning, implementing the finest advanced natural and conventional medicine treatments for cancer and chronic disease.